Skip to main content
. 2011 Sep 13;4:47–62. doi: 10.4137/CMED.S5976

Figure 4.

Figure 4

Comparison of liraglutide and sitagliptin. Changes in HbA1c (A) and body weight (B) and proportion of patients with nausea are plotted.21 Liraglutide significantly reduced HbA1c more than sitagliptin did, with greater reduction in body weight. Although nausea is more frequent in liraglutide groups, proportions of patients suffering from nausea become similar at the end of the trial. Reproduced from Partley et al., Lancet 2010; 375:1447–56, with permission from Elsevier, © 2009.